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Abstract: Composite materials are very promising bioma-
terials for hard tissue augmentation. The approach assayed
in this work involves the manufacturing of a composite
made of a bioactive ceramic, natural wollastonite (W) and a
nanostructured copolymer of ethylmethacrylate (EMA) and
vinylpyrrolidone (VP) to yield a bioresorbable and biocom-
patible VP–EMA copolymer. A bulk polymerization was
induced thermally at 508C, using 1 wt % azobis(isobutyroni-
trile) (AIBN) as free-radical initiator. Structural characteriza-
tion, compressive strength, ﬂexural strength (FS), degrada-
tion, bioactivity, and biocompatibility were evaluated in
specimens with a 60/40 VP/EMA ratio and ceramic content
in the range 0–60%. A good integration between phases
was achieved. Greater compression and FS, in comparison
with the pure copolymer specimens was obtained only
when the ceramic load got up to 60% of the total weight.
The soaking in NaCl solution resulted in the initial swelling
of the specimens tested. The maximum swelling was
reached after 2–3 h of immersion and it was signiﬁcantly
greater for lower ceramic loads. This result makes the poly-
mer component the main responsible for the interactions
with the media. After soaking in SBF, microdomains segre-
gation can be observed in the polymer component that can
be related with a dramatic difference in the reactivity of
both monomers in free radical polymerization, whereas the
formation of an apatite-like layer on the W surfaces can be
observed. Biocompatibility in vitro studies showed the ab-
sence of cytotoxicity of all formulations. The cells were able
to adhere on the polystyrene negative control and on speci-
mens containing 60 wt % wollastonite forming a monolayer
and showing a normal morphology. However, a low cellu-
lar growth was observed.  2008 Wiley Periodicals, Inc.
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INTRODUCTION
The design of biomaterials and scaffolds for hard
tissue engineering must allow ease of handling in
the preparation and implementation of implant mat-
erials; furthermore, the implants must have the
capacity to be trimmed or sculpted to exactly, ﬁt ev-
ery surgical site and exhibit a rapid and reproducible
degradation or dissolution process in every insertion
site.1
Mechanical stability and capacity for being osseoin-
tegrated are the key features for the success of a bone
substitute. Osseointegration requires matching the
degradation rate of the substitute to the growing rate
of the tissue.
Several approaches have been used to reach this
goal, mostly involving the introduction of a bioactive
ceramic such as hydroxyapatite2 or bioglass.3 Sev-
eral phase composites containing a resorbable poly-
mer and a reinforcing ceramic4 is between the most
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promising methods proposed though no ideal bone
prostheses have been produced yet.5
The approach suggested in this work involves the
manufacturing of a composite made of a bioactive
ceramic, natural wollastonite, and a nanostructured
copolymer with a biostable component, ethylmetha-
crylate (EMA) and a bioresorbable component, vinyl-
pyrrolidone (VP). These sort of multiphase materials
have also shown the ability to create porosity in situ
when they are in contact with physiological ﬂuids.6
There are two polymorphs of wollastonite; the high
temperature form known as pseudowollastonite (b-
CaSiO3, ps-W), and wollastonite-Tc (a-CaSiO3, W-Tc),
the form stable at temperatures below 11258C.7 Ps-W
ceramics react in simulated body ﬂuid (SBF) forming
an apatite layer on their surface.8 They are not cyto-
toxic9,10 and induce calciﬁcation in osteoblast cultures
in vitro.11,12 New woven bone is directly deposited on
ps-W implants during in vivo test in rat tibiae
also.13,14 Ps-W ceramics obtained by solid-state reac-
tion of synthetic precursors presented similar chemi-
cal, mechanical, and biological properties than ps-W
ceramics obtained by sintering powders of natural W-
Tc.10 W-Tc ceramics are not available because of the
low transition temperature to ps-W and the relatively
high temperature required for sintering and densiﬁca-
tion of the precursor powders into a ceramic body.
However, synthetic powders of W-Tc exhibit in vitro
bioactivity also.15 Wollastonite powders and sponges
have been employed as ﬁllers in several experimental
biomedical composites. Porous ceramic sponges of
synthetic ps-W impregnated with a mixture of EMA
and VP monomers rendered by thermal polymeriza-
tion reinforced and in vitro bioactive composites.16,17
Biomedical composites of powdered synthetic and
natural W-Tc with polymeric matrixes of poly(3-
hydroxybutirate-co-3-hydroxyvalerate)18–20 poly(D,L-lac-
tic acid),21 poly(butylene terephthalate),22 collagen23
and chitosan,24 have been reported, which exhibit
better mechanical strength and bioactivity with
regards to the polymer component alone.
Block copolymers of segments with different solu-
bility properties have been of considerable interest in
different ﬁelds such as sequestration of pollutants,
drug delivery, or gene therapy due to their ability to
self-assemble in bulk state.25 VP copolymers have
been tested as a vehicle for controlled local applica-
tion of growth factors. VP acts as a biodegradable
support containing the substance to be delivered
and the release rate is controlled by the resorption
proﬁle of the copolymer composition.26,27 VP has
also been tested for the release of the nonsteroidal
anti-inﬂammatory drug 2040-diﬂuoro-4-hydroxy-
(1,10biphenyl)-3-carboxylic acid28 and the immuno-
suppressor cyclosporine A.29 The proteic30 and
blood31 interactions of copolymers of VP have also
been studied.
Methacrylates have been used in the preparation of
acrylic cements32,33 used in surgery to ﬁx joint replace-
ments. PEMA bone cements have been investigated as
an alternative to PMMA due to their higher ductility,
lower toxicity, and exotherm,34 water absorption–
desorption characteristics, and interactions with the bi-
ological medium studied.35 PEMA derivates have
been studied for the preparation of intervertebral
cages36 and as carriers for the recombinant human
bone morphogenetic protein 237 and fosfosal.38
The production of composites based on the in situ
polymerization of EMA and VP with several
amounts of dispersed W-Tc is presented in this arti-
cle. The maximum ceramic load that can be achieved
is investigated and the inﬂuence of the ceramic load
on the resorption rate of the specimens and on the
features of the apatite layer growth when the speci-
mens are soaked in an acellular SBF is assessed. The
inﬂuence of the inorganic load in the biocompatibil-
ity of the system is also assessed.
The optimization of the resorption rate and the
control of the bioactivity in the design of hybrid
inorganic–organic composites is the goal pursued.
EXPERIMENTAL SECTION
Specimen preparation and characterization
A natural wollastonite (W-Tc) (Vansil1 W40, Vander-
bilt), with an average particle size of 13.2 lm and 1.056 6
0.001 SiO2/CaO molar ratio, was selected as the ceramic
component. Qualitative X-ray diffraction analysis showed
that the major crystalline phase was a-CaSiO3, also called
CaSiO3-Tc (JCPDF 43-1460). Minor amounts of prehnite
(2CaOAl2O33SiO2H2O, JCPDF 29-0290), and diopside (Ca
(Mg,Al)2(Si,Al)2O6, JCPDF 41-1370) were also detected.
10
1-Vinyl-2-pyrrolidone (VP) (Aldrich) and EMA (Acros)
were chosen as the organic components for the preparation
of the copolymer system.
Prior polymerization, VP, and EMA monomers were
distilled at reduced pressure. The monomers were mixed
in a VP/EMA 60/40 weight ratio and the ceramic compo-
nent added in different ceramic/polymer weight ratios:
0/100, 15/85, 30/70, and 60/40. The resulting specimens
will be named W0, W15, W30, and W60. A bulk polymer-
ization was induced thermally at 508C using 1 wt % azo-
bis(isobutyronitrile) (AIBN) as free-radical initiator by
introducing the desired composition into a 15 mm diame-
ter cylindrical plastic mold. The molds were ﬁlled to a
height of 100 mm. Discs of 1 mm height were sliced with
a diamond saw using alcohol as lubricant after removing
the cylinders from the mold and discarding 10 mm length
at each end. Plastic molds (6 mm) were also ﬁlled and
12 3 6 cylinders manufactured in the same way. 45 mm
length 3 6 mm width 3 4 m depth teﬂon molds were also
employed.
Specimens with a ceramic/polymer ratio 60/40 and
EMA as the solely organic component and ﬁlms without
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the ceramic component were fabricated in an analogous
manner for extra testing.
The specimens were characterized by thermogravimetric
analysis (TGA), differential scanning calorimetry (DSC), 1H
nuclear magnetic resonance (NMR), attenuated total reﬂec-
tance Fourier transformed infrared spectroscopy (ATR-
FTIR), X-ray diffraction (XRD), scanning electron micros-
copy (SEM) an atomic force microscopy (AFM).
TGA was performed in a Perkin–Elmer TGA 7, three
different slices were analyzed to calculate the average
value. 10–20 mg of the composites were heated at a 108C/
min rate between 50 and 6008C. DSC experiments were
performed in a Perkin–Elmer DSC7. The specimens were
heated between 35 and 2508C at a rate of 108C in ﬂowing
nitrogen gas. Glass transition temperature (Tg) was esti-
mated from the midpoint of the tangent at the inﬂection
point on the second heating scan. 1H NMR spectra were
recorded in a Bruker Avance-300 working at 300 MHz af-
ter extracting the polymeric component in CDCl3. ATR-
FTIR spectroscopy was performed with a Perkin–Elmer
Spectrum one spectrophotometer. Sixteen scans with a 2
cm21 resolution and 458 incident angle were recorded
between 600 and 4000 cm21 with a KBr window yielding
an analysis depth of 1–2 lm. XRD patterns were recorded
in a Siemens D5000 diffractometer in glazing angle mode
using CuKa radiation, 1.5418 A˚, at an incident angle of 0.5
between 2u 25 and 35 with a step of 0.02 A˚ and 10 second
per step. Scanning micrographs were taken with an envi-
ronmental microscope Phillips ESEM XL30 and a Hitachi
S4700 ﬁeld emission microscope ﬁeld emission microscope.
Energy dispersive X-ray analysis (EDAX) and X-ray map-
ping were applied to identify the elemental distribution.
AFM experiments were performed with a Nanoscope IVa
controller in a Veeco Multimode. The results were
obtained in tapping mode AFM with a phosphorous
doped Si cantilever with a oscillation frequency of 217–
249 kHz. The average roughness for each sample was cal-
culated directly from the AFM images.
Mechanical properties
Compressive strength (CS) was measured on the 12 3 6
mm2 cylinders with an Instrom universal testing machine
3366 with a 5 kN load cell and a crosshead speed of 0.5
mm min21. CS was calculated according to the 5833 ISO
Standard with the following formulae
CS ¼ F
A
ð1Þ
where F is the breakload and A the section area of the
specimen.
Flexural strength was measured in a three-point conﬁg-
uration in a Microtest EM/50/Fr equipped with a load cell
of 0.5 kN. The measurements were done following the
ASTM D 790-95a standard. The outer span was 25 mm
and the crosshead speed was 1mm min21. The ﬂexural
strength (FS) and ﬂexural modulus of elasticity (Ef) accord-
ing to the expressions valid for a three point bending con-
ﬁguration
FS ¼ 3PL
2bd2
ð2Þ
Ef ¼ L
3m
4bd3
where P is the breakload, L is the support span, b is the
specimen width, d is the specimen thickness, and m the
slope of the tangent to the initial line portion of the load
deﬂection curve. The results are the average of at least
ﬁve specimens.
Analysis of variance (ANOVA) was performed by using
Statistica 6.0 software (Statsoft, Tulsa, USA). The statistical
analysis of wollastonite reinforced specimens was made
with respect to wollastonite absent composition used as
control, *p < 0.05.
Degradation and bioactivity
The kinetics of water absorption and solubility was
studied by immersing disks (n 5 3) of 14 mm diameter
and 1 mm thickness in 9 g/L NaCl solution (0.1 mL/mm2)
at 36.58C and monitoring the weight of the damped disks
after different intervals of immersion time. The percent of
water uptake (Wt) was calculated from the initial dry mass
of the disks (m0) and the mass of the damped disks (mt) af-
ter certain immersion time by Eq. (4).
Wt ¼ ðmt m0Þ
m0
3 100
Solubility (S) in percent was calculated from m0 and the
mass of the disks after the longest immersion time, water
rinsing and drying to constant weight (mf), by using Eq.
(5).
S ¼ ðmf m0Þ
m0
3 100
In vitro bioactivity was tested by immersing disks into
Kokubo’s corrected SBF39 at 36.58C for up to 3 weeks. A
volume/area ratio of 0.5 mL/mm2 was used and the SBF
was removed and replaced with a fresh portion at alter-
nate days. Soaked specimens were analyzed by NMR,
ATR-FTIR, XRD, SEM, and AFM.
Biocompatibility studies
Phosphate buffered solution of pH 5 7.4 (Sigma) was
used as received. Thermanox1 (TMX) control discs were
supplied by Labclinics S. L. Tissue culture media, addi-
tives, trypsin and 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-
tetrazolium bromide (MTT), were all supplied by Sigma.
The fetal bovine serum was supplied by Gibco and the
Alamar Blue reagent by Serotec.
Specimens and cell culture medium
The negative control was tissue culture plastic, TMX,
and the positive control (toxic agent) was an aqueous solu-
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tion of Triton X-100. Discs of 10 mm diameter and 1 mm
thickness of the cured systems and the controls were used
for direct and indirect biocompatibility experiments. At the
beginning of the experiment all specimens were sterilized
with ethylene oxide. Some specimens were alternatively
sterilized with b-radiation. A dose of 20 kG was supplied
to the specimens using an electron accelerator Rhodotron
TT2 working at 50 kW and 10 Mev.
The cells used in the primary cell culture were human
ﬁbroblasts cultured at 378C in humidiﬁed air with 5%
CO2. The culture medium was minimal essential medium
Eagle (MEM), modiﬁed with HEPES [4-(2-hydroxyethyl)-1-
piperazine ethane sulfonic acid] (Sigma) and supple-
mented with 10% fetal bovine serum, 200 mMl-glutamine,
100 units/mL penicillin and 100 lg/mL streptomycin. The
culture medium was changed every 2 days with care to
cause little disturbance to culture conditions.
Environmental scanning electron microscopy
The materials were placed in a 24-well plate (in dupli-
cate) and seeded with ﬁbroblasts at a density of 14 3 104
cells/mL. These were incubated at 378C in humidiﬁed air
with 5% CO2. The cells were ﬁxed with 1.5 % glutaralde-
hyde buffered in 0.1M phosphate buffer after a 24-h incu-
bation period. The dried samples were sputter-coated with
gold before examination under an environmental scanning
electron microscopy (ESEM) apparatus (Philips XL 30) at
an accelerating voltage of 15 KeV.
MTT assay
To evaluate the cytotoxicity of the ‘‘leachables’’ obtained
from the cured cements, TMX, Triton and discs of formula-
tions were ﬁrst set up in 5 mL of MEM and placed on a
roller mixer at 378C. The medium was removed at 1, 2,
and 7 days, and replaced with 5 mL of fresh medium. All
the extracts were obtained under sterile conditions.
Human ﬁbroblasts were seeded at a density of 11 3 104
cells/mL in complete medium in a sterile 96-well culture
plate and incubated to conﬂuence. After 24 h of incubation
the medium was replaced with the corresponding dilution
or eluted extract and incubated at 378C in humidiﬁed air
with 5% CO2 for 24 h. A solution of MTT was prepared in
warm phosphate buffered solution (0.5 mg/mL) and the
plates were incubated at 378C for 4 h. Excess medium and
MTT were removed and 100 lL dimethylsulphoxide were
added to all wells to dissolve the MTT taken up by the
cells. This was mixed for 10 min and the absorbance was
measured with a Biotek ELX808IU spectrometer using a
test wave length of 570 nm and a reference wave length of
630 nm. The cell viability was calculated from Eq. (6):
Relative cell viability ð%Þ ¼ 100 3 ODS ODB
ODC
where ODS, ODB, and ODC are the optical density of form-
azan production for the sample, blank (MEM without
cells) and the corresponding control, respectively.
Alamar Blue assay
Human ﬁbroblasts were seeded at a density of 14 3 104
cell/mL over the testing dry specimens placed in 24-well
culture plate for 24 h. After that, 1 mL of Alamar Blue dye
(10% Alamar Blue solution in phenol red free DMEM me-
dium) was added to each specimen. After 4 h of incuba-
tion 100 lL (n 5 4) of culture medium for each test sample
were transferred to a 96-well plate, and the absorbance
was measured at 490 nm on a Biotek ELX808IU spectrome-
ter. The specimens were washed with phosphate buffered
solution twice to remove rest of the reagent, and 1 mL of
culture medium was added to monitor the cells over the
materials. This step was done at 4, 7, 14, and 21 days.
Statistical analysis of biocompatibility test
ANOVA was performed by using Statistica 6.0 software
(Statsoft, Tulsa, USA). The statistical analysis of MTT, Ala-
mar Blue was made with respect to TMX control, *p <
0.05.
RESULTS AND DISCUSSION
Specimen characterization
The specimens loaded with the ceramic component
were characterized ﬁrst by TGA. A weight loss
between 316 and 4808C can be observed for each of
the compositions analyzed as displayed in Figure 1
(dashed curves), which corresponded to the decom-
position and volatilization of the polymer component
on heating. From the weight loss ceramic/polymer
ratios of the specimens were calculated. Ceramic/
polymer weight ratios obtained for W15, W30, and
W60 are: 17/83, 33/67, and 72/28. The deviation
Figure 1. Weight loss on heating of the ceramic containing
compositions. W15, W30, and W60 from specimens as pre-
pared, S-W15, S-W30, and S-W60 from specimens soaked in
NaCl solution.
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from the ratios utilized for the synthesis was lower
than 3% for those specimens with less than 60% of
W-Tc theoretical contents suggesting a reliable prepa-
ration procedure. However, remarkable deviation
between theoretical and experimental W-Tc content
was observed for the specimen W60 probably due to
sedimentation of the ﬁller during the thermal poly-
merization in the cylindrical plastic moulds.
All the weight loss occurred in one single step at a
relatively high temperature but the relative stabiliza-
tion of thermal degradation with respect to pure
homopolymers have been reported for several sys-
tems including methacrylate units40,41 whereas the
cleavage of the pyrrolidone ring that could be
expected between 280 and 3008C has also been
observed at greater temperatures as a consequence
of the volatilization of the pyrrolidone residue that
proceeds from polyenic sequences formed at those
temperatures.40,41
The DSC analysis of the copolymer specimens
without the ceramic component showed a unique Tg
at about 608C that is very close to the theoretical
value for PEMA.42 When the ceramic component is
added the Tg value shifts to 888C, suggesting that an
interaction between the ceramic and the polymeric
components does happen. No signiﬁcant differences
could be appreciated between specimens with differ-
ent ceramic load.
Polymerization was conﬁrmed by 1H NMR spec-
troscopy. Figure 2 displays the spectrum of the co-
polymer for a W0 specimen. The spectrum corre-
sponds to a random EMA/VP copolymer with an
average weight composition 60/40 which was deter-
mined from the comparison of the resonance signals
of the oxyethylene groups of EMA units (4.1 ppm)
and those assigned to the pyrrolidone ring (3.4
ppm). Results for each of the compositions are
shown in Table I.
The SEM images and Ca and Si mappings dis-
played in Figure 3 show that the specimens are
made of acicular W-Tc particles distributed within a
homogeneous polymeric matrix. No cracks between
the organic and the inorganic phase can be observed
indicating that a good integration between phases
was achieved.
Mechanical properties
The CS results of the composite specimens are
shown in Table I. Compression strength is greater
for W60 than for the copolymer specimens W0. W30
and W15 compression strength results are not signif-
icantly different from W0. The elasticity modulus in
compression mode is also displayed in Table I. A
47% and 20 % increase for the W60 and W30 speci-
mens in comparison to the non-reinforced specimens
(W0) was obtained whereas the W15 composition
does not show a signiﬁcant increase in elastic modu-
lus compared with the non-reinforced specimen.
Flexural strength results are also collected in Table
I. Each of the ceramic reinforced compositions shows
a greater FS than the non-reinforced copolymer
specimens. Again, the maximum FS was achieved
for the composition with a 60% of ceramic load. W15
and W30 compositions showed no signiﬁcant differ-
ence between them, but their values are signiﬁcantly
lower than those of W60. The elasticity modulus cal-
culations in bending yield greater values for greater
ceramic loadings.
Bending fracture surfaces are displayed in Figure
4 revealing the inﬂuence of ﬁller particles on the de-
formation of the copolymer. W0 fracture surface is
Figure 2. Structure and spectrum of a W0 specimen.
TABLE I
Composition and Mechanical Properties of the Specimens
As Prepared Soaked in NaCl (0.9%) As Prepared
W
(wt %)
VP
(wt %)
EMA
(wt %)
W
(wt %)
VP
(wt %)
EMA
(wt %)
CS
(MPa)
Ec
(GPa)
FS
(MPa)
Ef
(GPa)
W0 0 60 40 0 60 40 42 (8) 2.8 (2) 20 (9) 0.184 (1)
W15 17 51 32 28 44 28 39 (14) 2.6 (5) 50 (10) 1.4 (3)
W30 33 42 25 48 30 22 40 (15) 3.4 (1) 59 (8) 3.0 (6)
W60 72 17 11 72 17 11 59 (9) 4.1 (1) 75 (9) 4.19 (5)
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Figure 3. SEM picture and Si and Ca mapping of W15 and W60 specimens.
Figure 4. Fracture surface and magniﬁcation of W0 (a,e); W15 (b,f); W30 (c,g); W60 (d,h).
shown in Figure 4(a) and a magniﬁcation is dis-
played in Figure 4(e). The polymer is highly
deformed with elongated domains that indicate a
ductile fracture. W15 fracture surfaces show ceramic
particles and agglomerates with copolymers domains
surrounding them with no apparent voids between
phases, domains are less deformed indicating a
lower ductile character of the fracture, Figure 4(b,f).
Broken ceramic particles and less deformed polymer
matrix were observed for greater ceramics loads
indicating fragile fractures, Figure 4(c–d,g–h).
Some studies in particulate ﬁlled resins have shown
that a low degree of adhesion between the particles
and the matrix produces a decrease in yield stress.43
Other studies in particulate ﬁlled PMMA cements
have shown that the poor adhesion between the ﬁller
and the matrix can be compensated by increasing the
ﬁller content resulting in constant values of the yield
stress.44 The studied compositions seem to reproduce
this compensation mechanism where only the effects
of the greater amount of ﬁller content totally over-
come the effect of the lack of adhesion resulting in a
greater compression strength. However, in bending
mode, the ceramic particles seems to interact with the
polymer repressing the ductile behavior of the poly-
mer as it can be observed in the fracture surface and
increasing the value of the fracture stress. Maximum
bending stress was reached at values over 50% of ﬁl-
ler content in good agreement with results obtained
in polyethylene composites.45 There are several mech-
anisms that can explain the improvement in the frac-
ture stress in bending of particulate reinforced poly-
mers, one of them is known as crack pinning.46 If a
crack begins to propagate within a material, the crack
front bows outward between two rigid particles
before breaking free. The crack front elongates as it
bows out, absorbing fracture energy. Separation of
the ﬁller from the matrix also absorbs energy. As the
advancing crack intersects with particles a further
opening of the tip requires extra energy to separate
the ﬁller matrix interfaces. Poorly bonded ﬁllers do
not contribute effectively to toughening through this
mechanism. Thus, the improvement in the bending
stress of the reinforced specimens together with the
shift from ductile to fragile behavior observed in the
scanning micrographs seems to indicate some sort of
interaction in the selected system.
Elastic modules in compression were all greater
than the elastic modulus of PMMA cements deter-
mined to be 1.6 GPa47 and closer to the compressive
modulus of compact bone for femur reported to be
up to 17 GPa48 and they are greater than the values
obtained for several calcium phosphate cements,
reported to range between 0 and 51 MPa.49 Thus,
these compositions have the mechanical behavior
appropriate to consider them as good candidates for
bone or dental replacement. However, wollastonite
Figure 5. Kinetics of water uptake for the noncharged co-
polymer and the experimental composites. : W0; :
W15; : W30; : W60.
Figure 6. SEM pictures of specimens soaked in SBF for 3 weeks, (a) W0; (b) W15; (c) W30, and (d) W60.
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seems to be little studied as ﬁller material in dental
replacements.50
Degradative behavior/bioactivity
The soaking in NaCl solution resulted in the initial
swelling of the specimens tested. The maximum
swelling was reached after 2–3 h of immersion and
it was signiﬁcantly greater for W0 and W15 than for
W30. The maximum swelling of W30 was also
greater than that of W60. These results make the
polymer component the main responsible for the
interactions with the media, which are the driving
forces of the water uptake. At the macroscopic scale,
the porosity of the polymer matrix should be the
main factor for water absorption through capillarity
phenomena, whereas in microscopic terms, the
highly hydrophilic VP rich moieties existing in the
copolymer chains must provide them with water-
binding capacity trough hydrogen and dipole–dipole
Van der Waals bonding. The matrix–ﬁller interface
seems to have none effect on the water absorption of
the composites.
The kinetic curves of Figure 5 also revealed that,
after reaching the corresponding values of maximum
swelling, the copolymer and the experimental com-
posites started to lose weight due to dissolution. The
values of S found were 35.9 6 1.6, 33.2 6 1.8, 24.9 6
1.5, and 13.9 6 2.0% for W0, W15, W30, and W60,
respectively, and diminished as the W-Tc content
increased suggesting that the EMA/VP copolymer is
more soluble than the W-Tc ﬁller. After ﬁnishing the
soaking in NaCl solution the specimens were sub-
mitted to NMR and TGA to determine possible
changes in copolymer composition and ceramic/
polymer weight ratio due to incongruent dissolution
of the composite.
Figure 7. AFM images of (a) VP/EMA 60/40; (b) EMA 100%; (c) VP/EMA 60/40 soaked CaCl2 48 h; (d) EMA 100%
soaked CaCl2 48 h. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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The results are shown in Table I. The ceramic/
polymer weight ratio grew after the immersion in
NaCl as expected, due to the partial dissolution of
the copolymer component of the composites whereas
the sparingly soluble W-Tc was not affected. How-
ever, the VP/EMA ratio in soaked samples remained
almost invariable (% 1.5 6 0.1) suggesting either
congruent dissolution of the copolymer or more
likely as it will be discussed later a dissolution of
the VP domains that remain absorbed on the surface
of the W component.51 This result indicates a homo-
geneous microstructure of the copolymer character-
ized by uniform distribution of both monomers in
the copolymer chains.
In contrast to as prepared composites, after soak-
ing in saline for 22 days the TGA curves of the
specimens W15, W30, and W60 presented multistep
weight reductions (Fig. 1, solid curves). The ﬁrst
step in weight loss between 60 and 1608C, ranging
between 1 and 3% and directly related to the poly-
mer content, could be assigned to the removal of
absorbed water. The second event started at 2808C
and extended to 375–4008C. The weight loss related
to this event were 38, 28, and 15% for W15, W30,
and W60, respectively, and is probably caused by
the releasing of pyrrolidone side groups40,41 and the
depolymerization of the saturated products of the
disproportion of poly(ethyl methacrylate) sequences
in the copolymer chains.52,53 From 375–3908C to
4608C a third step could be distinguished due to the
decomposition of the polyenic sequences remaining
from the poly(vinylpyrrolidone) moieties, into low-
molecular weight hydrocarbon compounds,40,41 as
well as the continuing depolymerization of the
products of disproportion of poly(ethyl methacry-
late).52,53 The corresponding weight loss were 31, 23,
and 12% for W15, W30, and W60, respectively. The
better resolution of the thermal effects in soaked
specimens can be explained by the increase of po-
rosity originated by partial dissolution of the poly-
meric matrix, which contributes to the faster re-
moval of the volatile decomposition products from
the composites bulk.
After soaking the specimens in SBF for a week, two
different phenomena were observed (a) in the poly-
meric matrix, a porous nanostructure was formed
[Fig. 6(a,b)] indicating microdomains of different solu-
bility. Those zones that appeared to be dissolved
should be related to the more resorbable VP rich
microdomains, whereas those zones that seems to be
unaffected by the immersion should correspond to
the more stable EMA rich domains. This microdo-
main segregation can be related with a dramatic dif-
ference in the reactivity of both monomers in free
radical polymerization; (b) on the W surfaces, the for-
mation of an apatite-like layer was observed by SEM
[Fig. 6(c)], which after studied by ATR-FTIR and low
angle XRD could be attributed to a carbohydroxyapa-
tite (CHA). The thickness of the layer is greater for
greater percentages of W. At 60 wt % of W all the
composite was covered with a thick layer of CHA.
The growing rate and thickness of the apatite layer
seems to be lower than the layer observed in other
systems.54 An inhibition of the growing of the apa-
tite layer is thought to be related to an interaction
between the VP component and the Ca of the SBF.
Films containing a 60/40% VP/EMA and 100%
EMA were prepared in an analogous way than the
former specimens and soaked in CaCl2 solution to
test this hypothesis. AFM analysis on the surfaces of
the ﬁlms permitted to appreciate the different behav-
ior of the ﬁlms whether VP was present or not. Fig-
ure 7(a,b) shows the surface of the VP/EMA 60/40
and EMA100 ﬁlms. The presence of VP leads the
mean roughness measured from the 1 lm scan of
the ﬁlms from Ra 0.294 nm for EMA100 to Ra 0.665
nm for VP/EMA60/40. After soaking, EMA 100 ﬁlm
surface seems similar than before but with a rough-
ness of Ra 0.665 nm. The surface of the VP/EMA
ﬁlm was not homogeneous anymore showing the
appearance of some structures that lead the rough-
Figure 8. FTIR spectra of (a) VP/EMA 60/40; (b) VP/
EMA 60/40 soaked CaCl2 48 h (c) EMA 100%; (d) EMA
100% soaked CaCl2 48 h.
BIOACTIVITY AND BIOCOMPATIBILITY OF NANOSTRUCTURED MATERIALS 61
Journal of Biomedical Materials Research Part A
ness to Ra 4.911 nm suggesting a stronger interaction
with the solution either with the water due to the
hydroscopic nature of the VP or with the calcium.
The IR spectrum of the 60/40 ﬁlm soaked for 48 h
[Fig. 8(b)] showed the disappearance of the band at
1629 cm21 assigned to the carbonyl group from the
VP component whereas no signiﬁcant differences
may be observed in the spectrum of the soaked
100% EMA ﬁlm, [Fig. 8(d)]. These results suggest the
interaction of the calcium with the VP component in
a way that can interfere with the initial stages of for-
mation of the layer of carbonateapatite in bioactive
materials.
Biocompatibility studies
Results of direct contact of cells with materials af-
ter 1 day of seeding are shown in Figure 9. In all
micrographs ﬂattened ﬁbroblasts were observed over
the surfaces. Fibroblasts showed no evidences of
morphological changes after 24 h of incubation in
the presence of W60 material when compared with
control independently of its form of sterilization: eth-
ylene oxide or b radiation.
MTT assay was used to measure cell metabolic
function. This test is dependent on the intact activity
of a mitochondrial enzyme, succinate dehydrogen-
ase, which may be impaired after exposure of cells
to toxic species.55 MTT results showed the absence
of mitochondrial damage in any of the experimental
formulations. All the compositions present a biocom-
patibility at least of the level or even superior than
the TMX control as can be seen in Figure 10.
Cell growth and proliferation were assessed by
Alamar Blue assay. AB is a redox indicator that
changes color with the chemical reduction of the cul-
ture medium occurring as the result of cells growth
and proliferation. This reagent can be withdrawn
and replaced with fresh medium, for monitoring cell
proliferation. It is soluble, stable in culture media
and nontoxic to cells.56
Results from this assay are shown in Figure 11.
The number of cells adhered to materials were less
than to the control, but when increasing the amount
of W in each formulation, cells growth and prolifer-
ate better, although without reaching the values for
the control. This behavior can be explained based
on the high roughness of the materials. It is known
that the cell behavior depends on surface roughness
and surface free energy.57
In vitro biocompatibility studies showed the ab-
sence of cytotoxicity of all formulations. The cells
Figure 9. SEM images (3500) of human ﬁbroblasts colonization over the control (TMX) (a), the W60 material sterilized
with ethylene oxide (b) and with b- radiation (c) at 1 day.
Figure 10. MTT cytotoxicity results for the control and
the ‘‘leachables’’ of test materials. Results are the mean 6
standard deviation; n 5 8; (*p < 0.05 respect to control).
Figure 11. Direct Alamar Blue results for control TMX
and formulations over a 21-day period. Results are the
mean 6 standard deviation; n 5 8; (*p < 0.05 respect to
control).
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were able to adhere on the TMX control and W60 for-
mulation forming a monolayer and showing a normal
morphology. However, there was less cellular growth
with respect to control (TMX) as it can be observed
in the Alamar Blue assay. This phenomenon may be
due to the surface properties. Surface roughness of
our specimens is very high and it is difﬁcult for cells
to adhere and growth. Glass ceramic formulations
with polished and smooth surfaces improve the cell
adhesion and cell proliferation.58
CONCLUSIONS
The results suggest that wollastonite-poly(VP-co-
EMA) composites provide with new bioactive mate-
rials that are able to develop nanoporous structures
in physiological conditions. Mechanical properties of
the system make it suitable for bone substitution.
The highest ceramic load is the most promising com-
position due to the combination of good mechanical
behavior, bioactivity, and biocompatibility with
appropriate surfaces for cell proliferation.
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